In agreement with our results, these CD133+CD44+ cancer cells have been characterized in several highly metastatic tumors such as CRCs (13–16), HCCs (17), pancreatic cancers (18), and gallbladder carcinoma (19). Here, PROM1 is linked to familial pancreatic carcinoma.